Browse through the entire archive of MasterControl news articles.
The U.S. Food and Drug Administration’s (FDA) multifaceted
responsibilities require continuous monitoring of trends in science and
technology for the advancement of public health.
Much of the growth was attributed to a surge in new cell and gene therapy
products.
Drug-delivery system innovation is on the rise as well. Nanotechnology is
currently being explored as a drug-delivery vehicle due to its ability to
provide site-specific and target-oriented delivery of medicines.
Read the full article
HERE.